Skip to main content

Impact BioMedical, Inc. (IBO) Stock

Impact BioMedical, Inc. Stock Details, Movements and Public Alerts

Stock Details

Impact BioMedical, Inc. (IBO), a prominent company in the healthcare sector within the biotechnology industry, is based in USA and primarily trades on the AMEX.Currently, the stock is trading at $0.50. Over the past 52 weeks, it has ranged between $0.36 and $6.17. This places the current price at 8.1% of its 52-week high and 38.1% above its 52-week low. Recent trading volume was recorded at 8,062. The 14-day Relative Strength Index (RSI) stands at 49.13, suggesting neutral conditions. The stock is currently trading below its 50-day moving average of $0.53 by 5.66%. Similarly, it is below its 200-day moving average of $0.69 by 27.54%. The MACD histogram is 0.01, indicating bullish momentum (MACD Line: -0.01, Signal Line: -0.02). There are currently 2 active alerts set for IBO by users.

52-Week Range

$6.17 - $0.36

-91.90% from high · +38.12% from low

Avg Daily Volume

139,838

20-day average

100-day avg: 193,461

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Price to Book

1.24

EV/EBITDA

4.72

EPS (TTM)

-$3.94

Price to Sales

1866.44

How is IBO valued relative to its earnings and growth?
Valuation data is not available for this stock.
What is IBO's risk profile compared to the market?
Risk profile data is not available for this stock.

Performance & Growth

Profit Margin

0.00%

Operating Margin

-5267.00%

EBITDA

$-3,126,000

Return on Equity

-347.00%

Return on Assets

-7.68%

Revenue Growth (YoY)

0.00%

Earnings Growth (YoY)

0.00%

How profitable and efficient is IBO's business model?
0 The operating margin of -5267.00% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -347.00% and ROA at -7.68%, the company achieves moderate returns on invested capital.
What are IBO's recent growth trends?
Growth data is not available for this stock.

Company Size & Market

Market Cap

$46.7M

Revenue (TTM)

$25,000

Revenue/Share (TTM)

$0.00

Shares Outstanding

104.62M

Book Value/Share

-$0.97

Asset Type

Common Stock

What is IBO's market capitalization and position?
Impact BioMedical, Inc. has a market capitalization of $46.7M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 104.62M shares outstanding, the company's ownership is relatively concentrated. As a participant in the BIOTECHNOLOGY industry, it competes with other firms in this sector.
How does IBO's price compare to its book value?
Impact BioMedical, Inc.'s book value per share is -$0.97, while the current stock price is $0.50, resulting in a price-to-book (P/B) ratio of -0.51. Trading below book value can indicate the market perceives challenges ahead, or it might represent a value opportunity if the assets are quality and earnings can recover. Value investors often screen for P/B ratios below 1.0. As a common stock, this represents equity ownership with voting rights.

Fundamentals last updated: Dec 1, 2025, 02:01 AM

Technical Indicators

RSI (14-day)

49.13

Neutral

50-Day Moving Average

$0.53

-5.66% below MA-50

200-Day Moving Average

$0.69

-27.54% below MA-200

MACD Line

-0.01

MACD Signal

-0.02

MACD Histogram

0.01

Bullish

What does IBO's RSI value tell investors?
The RSI (Relative Strength Index) for IBO is currently 49.13, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being below the 50-day moving average, this confirms bearish conditions.
How should traders interpret IBO's MACD and moving average crossovers?
MACD analysis shows the MACD line at -0.01 above the signal line at -0.02, with histogram at 0.01. This bullish crossover suggests upward momentum is building. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($0.53) is below the 200-day MA ($0.69), forming a death cross pattern that often warns of extended weakness. Price is currently below both MAs, confirming weakness.

Indicators last updated: Dec 12, 2025, 12:34 AM

Active Alerts

Alert Condition
Price decreases by
Threshold
10%
Created
Dec 9, 2025, 03:44 PM
Alert Condition
MA Breakout (Bullish)
Threshold
200 days
Created
Dec 8, 2025, 04:14 PM

Stay Ahead of the Market with Impact BioMedical, Inc. Alerts

Set up price alerts for Impact BioMedical, Inc. and get notified instantly when the price hits your target. Never miss an important price movement again.